{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:38:35Z","timestamp":1763037515525,"version":"3.37.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10067-020-05383-y","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T07:03:51Z","timestamp":1600671831000},"page":"2467-2476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acute severe hepatitis in adult-onset Still\u2019s disease: case report and comprehensive review of a life-threatening manifestation"],"prefix":"10.1007","volume":"40","author":[{"given":"Romain","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Briantais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Faucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Borentain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Nafati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Bernit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Seguier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Robert","family":"Harl\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Ebbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-3392","authenticated-orcid":false,"given":"Nicolas","family":"Schleinitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"issue":"5","key":"5383_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.autrev.2015.01.007","volume":"14","author":"N Narula","year":"2015","unstructured":"Narula N, Narula T, Abril A (2015) Seizing the clinical presentation in adult onset Still\u2019s disease. An extensive literature review. Autoimmun Rev 14(5):472\u2013477","journal-title":"Autoimmun Rev"},{"key":"5383_CR2","doi-asserted-by":"crossref","unstructured":"Gerfaud-Valentin M, Maucort-Boulch D, Hot A, Iwaz J, Ninet J, Durieu I, et al. (2014) Adult-onset Still disease. Medicine (Baltimore) 93(2)","DOI":"10.1097\/MD.0000000000000021"},{"issue":"11","key":"5383_CR3","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1872-034X.2010.00707.x","volume":"40","author":"A Takahashi","year":"2010","unstructured":"Takahashi A, Abe K, Yokokawa J, Iwadate H, Kobayashi H, Watanabe H, Irisawa A, Ohira H (2010 Nov) Clinical features of liver dysfunction in collagen diseases. Hepatol Res Off J Jpn Soc Hepatol 40(11):1092\u20131097","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"issue":"6","key":"5383_CR4","first-page":"284","volume":"15","author":"G Zhu","year":"2009","unstructured":"Zhu G, Liu G, Liu Y, Xie Q, Shi G (2009) Liver abnormalities in adult onset Still\u2019s disease: a retrospective study of 77 Chinese patients. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 15(6):284\u2013288","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"4","key":"5383_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/rheumatology\/keq397","volume":"50","author":"R Priori","year":"2011","unstructured":"Priori R, Barone F, Alessandri C, Colafrancesco S, McInnes B, Pitzalis C, Valesini G, Bombardieri M (2011) Markedly increased IL-18 liver expression in adult-onset Still\u2019s disease-related hepatitis. Rheumatology (Oxford) 50(4):776\u2013780","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"5383_CR6","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.autrev.2017.07.017","volume":"16","author":"M Govoni","year":"2017","unstructured":"Govoni M, Bortoluzzi A, Rossi D, Modena V (2017) How I treat patients with adult onset Still\u2019s disease in clinical practice. Autoimmun Rev 16(10):1016\u20131023","journal-title":"Autoimmun Rev"},{"issue":"3","key":"5383_CR7","first-page":"197","volume":"3","author":"S Kevat","year":"1988","unstructured":"Kevat S, Ahern M, Hall P (1988) Hepatotoxicity of methotrexate in rheumatic diseases. Med Toxicol Adverse Drug Exp. 3(3):197\u2013208","journal-title":"Med Toxicol Adverse Drug Exp."},{"key":"5383_CR8","doi-asserted-by":"crossref","unstructured":"Brok J, Buckley N, Gluud C. (2006) Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev (2):CD003328","DOI":"10.1002\/14651858.CD003328.pub2"},{"issue":"2","key":"5383_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5604\/01.3001.0010.8633","volume":"17","author":"L Meunier","year":"2018","unstructured":"Meunier L, Larrey D (2018) Recent advances in hepatotoxicity of non steroidal anti-inflammatory drugs. Ann Hepatol 17(2):187\u2013191","journal-title":"Ann Hepatol"},{"key":"5383_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2147\/IJGM.S23920","volume":"4","author":"M Mahamid","year":"2011","unstructured":"Mahamid M, Paz K, Reuven M, Safadi R (2011) Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports. Int J Gen Med 4:657\u2013660","journal-title":"Int J Gen Med"},{"issue":"11","key":"5383_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","volume":"13","author":"ATJ Maria","year":"2014","unstructured":"Maria ATJ, Le Quellec A, Jorgensen C, Touitou I, Rivi\u00e8re S, Guilpain P (2014) Adult onset Still\u2019s disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. Autoimmun Rev 13(11):1149\u20131159","journal-title":"Autoimmun Rev"},{"issue":"4","key":"5383_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.autrev.2006.08.010","volume":"6","author":"APN Lotito","year":"2007","unstructured":"Lotito APN, Silva CAA, Mello SBV (2007) Interleukin-18 in chronic joint diseases. Autoimmun Rev 6(4):253\u2013256","journal-title":"Autoimmun Rev"},{"key":"5383_CR13","doi-asserted-by":"crossref","unstructured":"Zhang Y, Yang Y, Bai Y, Yang D, Xiong Y, Zeng X (2016) Clinical characteristics and follow-up analysis of adult-onset Still\u2019s disease complicated by hemophagocytic lymphohistiocytosis. Clin Rheumatol 35(5):1145\u20131151","DOI":"10.1007\/s10067-016-3178-0"},{"issue":"5","key":"5383_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.autrev.2015.01.004","volume":"14","author":"P Ruscitti","year":"2015","unstructured":"Ruscitti P, Cipriani P, Di Benedetto P, Ciccia F, Liakouli V, Carubbi F et al (2015) Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still\u2019s disease, developing macrophage activation syndrome, correlate with the severity of the disease. Autoimmun Rev 14(5):429\u2013437","journal-title":"Autoimmun Rev"},{"key":"5383_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JBM.S46255","volume":"5","author":"MR George","year":"2014","unstructured":"George MR (2014) Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med 5:69\u201386","journal-title":"J Blood Med"},{"issue":"11","key":"5383_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.autrev.2014.05.009","volume":"13","author":"D Poddighe","year":"2014","unstructured":"Poddighe D, Cavagna L, Brazzelli V, Bruni P, Marseglia GL (2014) A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. Autoimmun Rev 13(11):1142\u20131148","journal-title":"Autoimmun Rev"},{"issue":"3","key":"5383_CR17","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.26592","volume":"59","author":"A Wree","year":"2014","unstructured":"Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, Hoffman HM, Feldstein AE (2014) NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59(3):898\u2013910","journal-title":"Hepatology"},{"key":"5383_CR18","first-page":"33","volume":"11","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux Y, Gerfaud-Valentin M, Henry T, S\u00e8ve P (2014) Treatment of adult-onset Still\u2019s disease: a review. Ther Clin Risk Manag 11:33\u201343","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"5383_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/1744666X.2019.1707664","volume":"16","author":"P Sfriso","year":"2020","unstructured":"Sfriso P, Bindoli S, Doria A, Feist E, Galozzi P (2020) Canakinumab for the treatment of adult-onset Still\u2019s disease. Expert Rev Clin Immunol 16(2):129\u2013138","journal-title":"Expert Rev Clin Immunol"},{"key":"5383_CR20","doi-asserted-by":"crossref","unstructured":"Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E et al (2017) Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset Still\u2019s disease: a multicentre retrospective observational study. Front Pharmacol 13","DOI":"10.3389\/fphar.2017.00369"},{"issue":"1","key":"5383_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13075-019-2021-9","volume":"21","author":"S Colafrancesco","year":"2019","unstructured":"Colafrancesco S, Manara M, Bortulozzi A et al (2019) Management of adult-onset Still\u2019s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts. Arthritis Res Ther 21(1):275","journal-title":"Arthritis Res Ther"},{"key":"5383_CR22","doi-asserted-by":"crossref","unstructured":"Cipriani P, Ruscitti P, Carubbi F, Pantano I, Liakouli V, Berardicurti O, Giacomelli R (2014 Jan) Tocilizumab for the treatment of adult-onset Still\u2019s disease: results from a case series. Clin Rheumatol 33(1):49\u201355","DOI":"10.1007\/s10067-013-2381-5"},{"key":"5383_CR23","doi-asserted-by":"crossref","unstructured":"Mimura T, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, Kawaguchi Y, Kono H, Takasaki Y, Takei S, Nishimoto N, Fujimoto M, Asanuma YF, Mimori A, Okiyama N, Kaneko S, Takahashi H, Yokosawa M, Sumida T (2018) Evidence-based clinical practice guideline for adult Still\u2019s disease. Mod Rheumatol 28(5):736\u2013757","DOI":"10.1080\/14397595.2018.1465633"},{"key":"5383_CR24","doi-asserted-by":"crossref","unstructured":"Nordstr\u00f6m D, Knight A, Luukkainen R, van Vollenhoven R, Rantalaiho V, Kajalainen A et al (2012) Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still\u2019s disease. An open, randomized, multicenter study. J Rheumatol 39(10):2008\u20132011","DOI":"10.3899\/jrheum.111549"},{"key":"5383_CR25","unstructured":"PNDS Maladie de Still de l\u2019adulte et de la forme syst\u00e9mique de l\u2019Arthrite Juv\u00e9nile Idiopathique ayant \u00e9volu\u00e9 jusqu\u2019\u00e0 l\u2019\u00e2ge adulte. Haute Autorit\u00e9 de Sant\u00e9. https:\/\/www.has-sante.fr\/jcms\/c_2867360\/fr\/maladie-de-still-de-l-adulte. Accessed 2020 Apr 25"},{"key":"5383_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S2665-9913(20)30096-5","volume":"2","author":"P Mehta","year":"2020","unstructured":"Mehta P et al (2020) Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol 2:358\u2013367","journal-title":"Lancet Rheumatol"},{"key":"5383_CR27","doi-asserted-by":"crossref","unstructured":"Kumar A, Kato H (2016) Macrophage activation syndrome associated with adult-onset Still\u2019s disease successfully treated with anakinra, case reports in rheumatology, vol 2016 Article ID 3717392, p 5","DOI":"10.1155\/2016\/3717392"},{"issue":"6","key":"5383_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jbspin.2013.04.011","volume":"80","author":"C Banse","year":"2013","unstructured":"Banse C, Vittecoq O, Benhamou Y, Gauthier-Prieur M, Lequerr\u00e9 T, L\u00e9vesque H (2013) Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still\u2019s disease. Joint Bone Spine 80(6):653\u2013655","journal-title":"Joint Bone Spine"},{"key":"5383_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13075-019-1838-6","volume":"21","author":"F Vercruysse","year":"2019","unstructured":"Vercruysse F, Bametche T, Lazaro E et al (2019) Adult-onset Still\u2019s disease biological treatment strategy may depend on the phenotypic dichotomy. Arthritis Research & Therapy 21:53","journal-title":"Arthritis Research & Therapy"},{"key":"5383_CR30","doi-asserted-by":"crossref","unstructured":"Drepper M, Rubbia-Brandt L, Spahr L. (2013) Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's Disease, Case Reports Hepatol 2013: 964828","DOI":"10.1155\/2013\/964828"},{"key":"5383_CR31","unstructured":"(1994) A case of adult-onset Still disease combined with severe liver injury\/disseminated intravascular coagulation (DIC), Internal Medicine Journal 83 (10) 117\u2013119"},{"issue":"2","key":"5383_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2177\/jsci.18.256","volume":"18","author":"C Hisano","year":"1995","unstructured":"Hisano C, Nakamura M, Mayumi T, Hayashida K, Kaji Y, Nagasawa K, Niho Y, Fukuda T, Tsuneyoshi M, Oshima K (1995) A case of hemophagocytic syndrome manifesting adult Still\u2019s disease and acute hepatitis. Jpn J Clin Immunol. 18(2):256\u2013264","journal-title":"Jpn J Clin Immunol."},{"issue":"4","key":"5383_CR33","first-page":"784","volume":"23","author":"O Dino","year":"1996","unstructured":"Dino O, Provenzano G, Giannuoli G, Sciarrino E, Pouyet M, Pagliaro L (1996) Fulminant hepatic failure in adult onset Still\u2019s disease. J Rheumatol 23(4):784\u2013785","journal-title":"J Rheumatol."},{"issue":"5","key":"5383_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2177\/jsci.20.447","volume":"20","author":"M Ishikawa","year":"1997","unstructured":"Ishikawa M, Masumoto T, Oguni T, Hyoudou N, Michitaka K, Horiike N et al (1997) A case of hemophagocytic syndrome with severe liver injury manifestating adult Still\u2019s disease. Nihon Rinsho Meneki Gakkai Kaishi 20(5):447\u2013452","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi."},{"key":"5383_CR35","unstructured":"Farlane M, Hart M, Wall WJ (1997) Liver transplant in adult Still\u2019s disease. J Rheumatol 24(10):2038\u20132041"},{"key":"5383_CR36","doi-asserted-by":"crossref","unstructured":"Takeshita A, Takeuchi T, Nakagawa A, Tsuda Y, Fukuda A, Nariyama K et al (2000) Adult onset Still\u2019s disease with hemophagocytic syndrome and severe liver dysfunction. Hepatol Res Off J Jpn Soc Hepatol 17(2):139\u2013144","DOI":"10.1016\/S1386-6346(99)00071-6"},{"key":"5383_CR37","doi-asserted-by":"crossref","unstructured":"Yamanaka J, Saito S, Kuroda N, Hirano T, Fujimoto J (2003) Successful living related liver transplantation for adult Still\u2019s disease. J Gastroenterol Hepatol 18(9):1109\u20131110","DOI":"10.1046\/j.1440-1746.2003.03060.x"},{"key":"5383_CR38","doi-asserted-by":"crossref","unstructured":"Omagari K, Matsunaga Y, Yamashita H, Nishiyama H, Hazama H, Oda H et al (2003) Successful treatment with cyclosporin in adult-onset Still disease manifesting as acute hepatitis with marked hyperferritinemia. Am J Med Sci 326(3):148\u2013151","DOI":"10.1097\/00000441-200309000-00009"},{"key":"5383_CR39","unstructured":"Ogata A, Kitano M, Yamanaka J, Yamasaki T, Hashimoto N, Iwasaki T, Hamano T, Fujimoto J, Kakishita E (2003) Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still\u2019s disease. J Rheumatol 30(5):1093\u20131096"},{"key":"5383_CR40","doi-asserted-by":"crossref","unstructured":"Aly L, Iking-Konert C, Quaas A, Benten D (2013) Subacute liver failure following anakinra treatment for adult-onset Still disease. J Rheumatol 40(10):1775\u20131777","DOI":"10.3899\/jrheum.121309"},{"key":"5383_CR41","unstructured":"Michel M, Duvoux C, Hezode C, Cherqui D (2003) Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still\u2019s disease. J Rheumatol 30(7):1624\u20131625"},{"key":"5383_CR42","doi-asserted-by":"crossref","unstructured":"Linde B, Oelzner P, Katenkamp K, Hein G, Wolf G (2007) Fulminantes Leberversagen bei einer 39-j\u00e4hrigen Patientin mit Leukozytose, unklaren Fiebersch\u00fcben und Arthralgien. Med Klin 102(10):846\u2013851","DOI":"10.1007\/s00063-007-1103-7"},{"key":"5383_CR43","doi-asserted-by":"crossref","unstructured":"Taccone FS, Lucidi V, Donckier V, Bourgeois N, Decaux G, Vandergheynst F (2008) Fulminant hepatitis requiring MARS and liver transplantation in a patient with Still\u2019s disease. Eur J Intern Med 19(6):e26\u2013e28","DOI":"10.1016\/j.ejim.2007.06.025"},{"key":"5383_CR44","unstructured":"Mm T, Kk S, Sm M, R G (2009) Adult onset Still\u2019s disease as a cause of acute liver failure. Trop Gastroenterol 29(1):35\u201336"},{"key":"5383_CR45","doi-asserted-by":"crossref","unstructured":"Ter\u00e1n A, Casafont F, F\u00e1brega E, Mart\u00ednez-Taboada VM, Rodr\u00edguez-Valverde V, Pons-Romero F (2009) Adult-onset Still\u2019s disease with liver failure requiring liver transplantation. Gastroenterol Hepatol 32(10):681\u2013686","DOI":"10.1016\/j.gastrohep.2009.06.009"},{"issue":"12","key":"5383_CR46","first-page":"841","volume":"7","author":"T Hogan","year":"2011","unstructured":"Hogan T, Kao KT, Tung J (2011) A rare case of severe acute hepatitis associated with adult-onset Still disease dramatically improved by high-dose steroid therapy. Gastroenterol Hepatol 7(12):841\u2013844","journal-title":"Gastroenterol Hepatol."},{"key":"5383_CR47","doi-asserted-by":"crossref","unstructured":"Gelley F, Doros A, Micsik T, Fazakas J, Fehervari I, Z\u00e1dori G et al (2011) Acute liver transplantation in a 41-year-old male patient presenting symptoms of adult-onset Still\u2019s disease. Interv Med Appl Sci 3:9\u201313","DOI":"10.1556\/imas.3.2011.1.3"},{"key":"5383_CR48","doi-asserted-by":"crossref","unstructured":"Satapathy SK, Isabel Fiel M, Del Rio MJ, Aloman C, Schiano TD (2010) Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still\u2019s disease. Hepatol Int 5(1):597\u2013602","DOI":"10.1007\/s12072-010-9218-y"},{"key":"5383_CR49","doi-asserted-by":"crossref","unstructured":"Yilmaz S, Cinar M, Simsek I, Erdem H, Pay S (2014 Nov) Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still\u2019s Disease. Mod Rheumatol 24(6):1030\u20131031","DOI":"10.3109\/14397595.2013.854437"},{"key":"5383_CR50","doi-asserted-by":"crossref","unstructured":"Singh B, Biboa J, Musuku S, Patel C, Pugh JL, Boyer TD (2013) Reversal of severe hepatitis with infliximab in adult-onset Still\u2019s disease. Am J Med 126(2):e3\u2013e4","DOI":"10.1016\/j.amjmed.2012.08.003"},{"key":"5383_CR51","doi-asserted-by":"crossref","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, D\u00e9cary F, Salusinsky-Sternbach M et al (1991) Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70(2):118\u2013136","DOI":"10.1097\/00005792-199103000-00004"},{"key":"5383_CR52","doi-asserted-by":"crossref","unstructured":"Pay S, T\u00fcrk\u00e7apar N, Kalyoncu M, Sim\u015fek I, Beyan E, Ertenli I, Ozt\u00fcrk MA, D\u00fczg\u00fcn N, Erdem H, Ozbalkan Z, Kiraz S, Kinikli G, Besbas N, Din\u00e7 A, Ate\u015f A, Olmez U, Calg\u00fcneri M, Aydintu\u011f OT, Bakkalo\u011flu A, Turan M, Turgay M, Karaaslan Y, Topalo\u011flu R, Duman M, Ozen S, Ankara Rheumatology Study Group (2006 Sep) A multicenter study of patients with adult-onset Still\u2019s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 25(5):639\u2013644","DOI":"10.1007\/s10067-005-0138-5"},{"key":"5383_CR53","doi-asserted-by":"crossref","unstructured":"Cagatay Y, Gul A, Cagatay A, Kamali S, Karadeniz A, Inanc M, Ocal L, Aral O, Konice M (2009) Adult-onset Still\u2019s disease. Int J Clin Pract 63(7):1050\u20131055","DOI":"10.1111\/j.1742-1241.2007.01393.x"},{"key":"5383_CR54","doi-asserted-by":"crossref","unstructured":"Kong X-D, Xu D, Zhang W, Zhao Y, Zeng X, Zhang F (2010) Clinical features and prognosis in adult-onset Still\u2019s disease: a study of 104 cases. Clin Rheumatol 29(9):1015\u20131019","DOI":"10.1007\/s10067-010-1516-1"},{"key":"5383_CR55","doi-asserted-by":"crossref","unstructured":"Chen P-D, Yu S-L, Chen S, Weng X-H (2012) Retrospective study of 61 patients with adult-onset Still\u2019s disease admitted with fever of unknown origin in China. Clin Rheumatol 31(1):175\u2013181","DOI":"10.1007\/s10067-011-1798-y"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05383-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:57:55Z","timestamp":1659059875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05383-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5383"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05383-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The patient has consented to the publication of this case report.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}